Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RALOXIFENE vs RAMUCIRUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RALOXIFENE vs RAMUCIRUMAB: Safety Overview

Metric RALOXIFENE RAMUCIRUMAB
Total FAERS Reports 4,185 5,357
Deaths Reported 34 1,444
Death Rate 0.8% 27.0%
Hospitalizations 346 2,066
Average Patient Age 67.7 yrs 63.9 yrs
% Female Patients 99.7% 33.0%
FDA Approval Date Apr 8, 2016 N/A
Manufacturer American Health Packaging Eli Lilly and Company
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription